Sparking New Discoveries for Parkinson’s Disease
The Collaborative Research Network (CRN) is a first-of-its-kind global community of multidisciplinary and multi-institutional teams working together to spark new discoveries in Parkinson’s disease (PD) research. The CRN is a program of the Aligning Science Across Parkinson’s (ASAP) initiative, managed by the Coalition for Aligning Science and implemented by the Michael J. Fox Foundation.
Our Research Network
The ASAP CRN supports 35 research teams across 14 countries, focusing on critical areas such as functional genomics in Parkinson’s disease, neuro-immune interactions, circuitry and brain-body interactions. With collaboration at its core, the CRN brings together hundreds of investigators to share expertise, findings, and tools in an effort to tackle challenges in the PD space. As a community, we promote standards for openness, real-world utility, and collective impact across scientific research.
An ASAP Program
An ASAP Program
The Aligning Science Across Parkinson’s (ASAP) initiative launched the CRN in 2020 to catalyze breakthroughs in PD research. ASAP fosters connections across the scientific community by supporting a variety of programs designed to enhance collaboration and promote sharing of scientific findings, tools, and technologies.
Impact
From the beginning, the CRN has been committed to providing resources, addressing research bottlenecks, and fostering innovation to build a thriving research ecosystem that advances Parkinson’s disease research.
Impact
From the beginning, the CRN has been committed to providing resources, addressing research bottlenecks, and fostering innovation to build a thriving research ecosystem that advances Parkinson’s disease research.
Latest CRN Highlights
Members of the CRN work diligently to advance our understanding of Parkinson’s disease. Learn more about recent CRN discoveries and achievements.
ASAP Research Round-Up | Q1 2026
Review Q1 2026 highlights from across ASAP's portfolio, showcasing efforts to advance Parkinson’s discovery, facilitate the rapid global exchange of ideas, broaden open-science accessibility, and support the next generation of Parkinson’s researchers.
GP2 Visits Nigeria: Commissioning of Nigeria’s First Molecular Laboratory for Parkinson’s Disease Genetics
Located within the Kesington Adebukunola Adebutu Research Centre (KAARC), the GP2-College of Medicine University of Lagos (CMUL) Molecular Laboratory for Parkinson’s Disease Research's goal is to extract and analyze DNA from Nigerian patients on-site, ensuring that West African ancestry genetic sequences are no longer underrepresented but are instead a driving contributor to global research.
Listen: Building a Global Genetic Map of Parkinson’s with Andy Singleton and Ignacio Mata
Listen as Andy Singleton, co-lead of the Global Parkinson's Genetics Program (GP2), and Nacho Mata, Cleveland Clinic geneticist and LARGE-PD founder, discuss how GP2 is accelerating discovery and expanding global representation in Parkinson’s research.